Genetically-informed treatment for advanced and metastatic prostate cancer

Alicia K. Morgans, Brittany M. Szymaniak

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The landscape of genetic testing for prostate cancer is rapidly evolving. There is increasing evidence that individuals with germline mutations in DNA-repair genes are more responsive to targeted therapies. Due to potential implications for treatment, these genes should be taken into consideration when determining the scope of genetic testing.

Original languageEnglish (US)
Pages (from-to)54-56
Number of pages3
JournalThe Canadian journal of urology
Volume26
Issue number5S2
StatePublished - Oct 1 2019

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Genetically-informed treatment for advanced and metastatic prostate cancer'. Together they form a unique fingerprint.

  • Cite this